Dazzi Francesco, Ramasamy Rajesh, Glennie Sarah, Jones Simon P, Roberts Irene
Department of Immunology, Faculty of Medicine, Hammersmith Campus, Imperial College London, Du Cane Road, London, UK.
Blood Rev. 2006 May;20(3):161-71. doi: 10.1016/j.blre.2005.11.002. Epub 2005 Dec 20.
The ontogeny of haemopoiesis during fetal life and the differentiation of blood cells in adult life depend upon a fully competent microenvironment to provide appropriate signals via production of soluble factors and cell contact interactions. The cellular constituents of the microenvironment, also defined as the haemopoietic niche, largely derive from a common progenitor of mesenchymal origin. Mesenchymal stem cells (MSC), initially identified in adult bone marrow, have also been described in fetal haemopoietic tissues where they accompany the migration of haemopoietic development. Their precise identity remains ill-defined because of the lack of specific markers. Their ability to self-renew and differentiate into tissues of mesodermal origin (osteocytes, adipocytes, chondrocytes) and their lack of expression of haemopoietic molecules are currently the main criteria for isolation. In the bone marrow the most important elements of the niche appear to be osteoblasts, whilst a less defined population of fibroblasts regulates the maturation of immature T cells in the thymus. Recently, MSC have been shown to exert a profound immunosuppressive effect on polyclonal as well as antigen-specific T cell responses by inducing a state of division arrest anergy. Thus, the multipotent capacity of MSC, their role in supporting haemopoiesis, and their immunoregulatory activity make MSC particularly attractive for therapeutic exploitation.
胎儿期造血的个体发生以及成年期血细胞的分化取决于一个功能完备的微环境,该微环境通过产生可溶性因子和细胞接触相互作用来提供适当的信号。微环境的细胞成分,也被定义为造血龛,很大程度上来源于间充质起源的共同祖细胞。间充质干细胞(MSC)最初在成人骨髓中被鉴定出来,在胎儿造血组织中也有描述,它们伴随着造血发育的迁移。由于缺乏特异性标志物,它们的确切身份仍不明确。它们自我更新和分化为中胚层起源组织(骨细胞、脂肪细胞、软骨细胞)的能力以及它们不表达造血分子,目前是分离的主要标准。在骨髓中,龛的最重要成分似乎是成骨细胞,而在胸腺中,一群不太明确的成纤维细胞调节未成熟T细胞的成熟。最近,已表明MSC通过诱导分裂停滞无反应状态,对多克隆以及抗原特异性T细胞反应发挥深远的免疫抑制作用。因此,MSC的多能性、它们在支持造血中的作用以及它们的免疫调节活性,使得MSC在治疗应用方面特别具有吸引力。